Choose a language

Offices

Locate all our offices easily
See all

Back

Corporate Social Responsibility

A responsible way to create value

At Andbank we understand corporate social responsibility as an essential part of our business model and our relationship with customers, professionals, society and the environment.

Our way of making progress

We integrate environmental, social and good governance (ESG) criteria into our decision-making to generate long-term value and contribute to the sustainable development of the countries where we are present.

Responsible banking: Ethics, transparency and customer protection

Responsible investment: Integration of ESG criteria

Social commitment: Health, inclusion and training

Environment: Efficiency and responsible management

Our model, responsibility begins in our activity

Responsible banking combines advice, innovation and friendly service with integrity and prudent risk management.

Responsible banking, trust, ethics and transparency

Our framework of good governance and regulatory compliance establishes common principles for the entire organisation and protects the interests of our customers.

Data protection and confidentiality

Prevention of conflicts of interest

Prudent risk management

Consultation and complaint channels

Responsible investment, forward-looking decisions

We integrate environmental, social and good governance criteria into certain investment strategies to identify risks, detect opportunities and promote sustainable value creation.

Adherence to the Principles for Responsible Investment (PRI)

Solutions with ESG criteria

Investment linked to social impact

Our priority cause, commitment to cancer research

Supporting research to fight cancer constitutes the main pillar of the Andbank Group’s corporate social responsibility.

We collaborate with hospitals, research centres and leading foundations to foster new treatments, support scientific talent and improve the care and quality of life of patients and their families.

The FERO Cancer Foundation and the VHIO

  • Andbank has been collaborating since 2015 with the FERO Cancer Foundation and the Vall d’Hebron Institute of Oncology (VHIO), two leading bodies in driving cancer research and the development of innovative treatments.
  • The FERO Cancer Foundation promotes translational research, enabling scientific advances to reach patients more quickly. For its part, the VHIO conducts pioneering research aimed at improving the prevention, diagnosis and treatment of the disease.
  • This collaboration reflects our commitment to research capable of transforming scientific knowledge into new opportunities for patients.

SJD Paediatric Cancer Centre Barcelona

  • Andbank is a founding partner of SJD Paediatric Cancer Centre Barcelona, a world-leader in children’s cancer research and care.
  • An initiative of Sant Joan de Déu Barcelona Children’s Hospital, the centre integrates patient care, research and the development of new treatments within a single facility. Its model allows it to offer highly specialised care and advance knowledge of paediatric cancers.
  • Andbank’s involvement reflects its commitment to contributing to a project with great social impact, aimed at improving the care of children and young people with cancer and supporting their families throughout the process.

CRIS Cancer Foundation

  • The CRIS Cancer Foundation is an independent body dedicated to fostering and funding research projects aimed at developing new cancer treatments.
  • Andbank collaborates with several initiatives related to research projects, including the application of computational chemistry and artificial intelligence to the discovery of new drugs.
  • Through this collaboration we contribute to accelerating research and facilitating the development of more effective treatments for patients.

Contigo Foundation

  • The Contigo Foundation fosters clinical and translational research projects focused on cancers that affect women.
  • Andbank supports its initiatives and collaborates with its charity gala to contribute to the funding of research, the development of new treatments and the improvement of the quality of life of patients.
  • This collaboration is part of the Group’s commitment to organisations that work to transform scientific advances into solutions applicable to clinical practice.

Investment with an impact. The Smart Horizon fund allocates 9% of its management fee and 10% of its success fee to cancer research.

Environment, more efficient and responsible management

We work to reduce the environmental impact of our activity and move towards more sustainable operations.

Efficient use of energy

Reduction of paper consumption

Digitalisation of processes and communications

Selective collection and recycling of waste

Periodic monitoring of environmental indicators

For further information, consult the Andbank Group Annual Report

Related pages

This site is registered on wpml.org as a development site.